BAYER AG |
Market Closed -
Other stock markets
|
After market 20:03:37 | |||
| 27.59 EUR | +0.69% |
|
27.48 | -0.41% |
| 12:31pm | Bayer: positive results with Eylea in ophthalmology | CF |
| 11:23am | Roche Holding AG: slimming down |  |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
28/04/2024
- Ex-dividend day for final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.4
EUR
Average target price
36.9
EUR
Spread / Average Target
+34.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.96% | 28.74B | |
| +25.88% | 661B | |
| +26.74% | 566B | |
| -6.72% | 352B | |
| +19.08% | 332B | |
| +3.27% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.20% | 145B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Starts Partnership With M2i To Distribute Pheromone-based Crop Protection Products
